UroGen Pharma (URGN) Tax Rate (2019 - 2026)
UroGen Pharma's (URGN) quarterly Tax Rate came in at 16.83% in Q1 2026, up 1774.0% YoY from 0.9% in Q1 2025, and down 87.42% on a QoQ basis from 133.79% in Q4 2025.
Powered by 
Analysis
UroGen Pharma (URGN) Tax Rate (2019 - 2026) Analysis & Trends
UroGen Pharma (URGN) has 7 years of Tax Rate data on file, last reported at 16.83% in Q1 2026.
- Quarterly Tax Rate rose 1774.0% year-over-year to 16.83% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 29.25% (up 840.0% YoY) and the FY2025 annual result came in at 23.0%, changed 0.0% from the prior year.
- Tax Rate slipped to 16.83% in Q1 2026, from 133.79% in the prior quarter.
- In the past five years, Tax Rate ranged from a high of 133.79% in Q4 2025 to a low of 2.82% in Q3 2022.
- A 5-year average of 24.84% and a median of 0.11% in 2024 frame the typical range for Tax Rate.
- Annual changes were most pronounced in 2024 — Tax Rate tumbled 1998 bps — and 2025, when it surged 5143 bps.
- Tracing URGN's Tax Rate over 5 years: stood at 91.96% in 2022, then increased by 11 bps to 102.34% in 2023, then fell by 20 bps to 82.36% in 2024, then surged by 62 bps to 133.79% in 2025, then slumped by 87 bps to 16.83% in 2026.
- The last three Tax Rate figures came in at 16.83% (Q1 2026), 133.79% (Q4 2025), and 3.06% (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 20.98% |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 15.11% |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | -10.89% |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -1.96% |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 24.15% |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 7.49% |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -16.71% |
| 10 | UroGen Pharma | 2.23 Bn | 2.12 Bn | 65.88 Mn | -64.54% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -64.54% |
| Mar 31, 2026 | 16.83% |
| Dec 31, 2025 | 133.79% |
| Sep 30, 2025 | 3.06% |
| Jun 30, 2025 | -2.07% |
| Mar 31, 2025 | -0.90% |
| Dec 31, 2024 | 82.36% |
| Sep 30, 2024 | -0.39% |
| Jun 30, 2024 | -0.11% |
| Mar 31, 2024 | -0.17% |
| Dec 31, 2023 | 102.34% |
| Sep 30, 2023 | 0.04% |
| Jun 30, 2023 | -0.22% |
| Mar 31, 2023 | -0.07% |
| Dec 31, 2022 | 91.96% |
| Sep 30, 2022 | -2.82% |
| Jun 30, 2022 | -0.12% |
| Mar 31, 2022 | -1.16% |
| Dec 31, 2021 | 93.23% |
| Jun 30, 2021 | -1.20% |